跳至主要内容
临床试验/NCT02586883
NCT02586883已完成不适用

Study of the Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2016年3月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
2
主要终点
Response to isoproterenol in solution without chloride ions during bronchial potential difference test (ΔIsoprotérénol / bronchial).

研究概览

简要总结

The purpose of this study is to identify the abnormalities of bronchial trans-epithelial transport of chloride, sodium and bicarbonate in patients with idiopathic dilations of the bronchi.

详细描述

Dilations of the bronchi happens for one child over 3000. The extended forms may progress to respiratory failure. More than one case over two remains of undetermined cause. If the prototype is the cystic fibrosis, other abnormalities of ionic transport may be the cause of a failure of mucociliary clearance and enhance the idiopathic dilations of the bronchi.

The purpose of this study is to identify the abnormalities of bronchial trans-epithelial transport of chloride, sodium and bicarbonate in patients with idiopathic dilations of the bronchi, in comparison to two others groups of patients (without abnormality of ionic transport/with typical cystic fibrosis).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
2 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Common criteria for all patients
  • Age between 2 and 20 years.
  • Patient weighing more than 12kg
  • Patients with a scheduled bronchoscopy under clinical monitoring (assessment of bronchial involvement, local samples for bacteriological and histological examination)
  • Signature of consent by the patient or by the / the holder (s) of parental authority and the investigator
  • Patient affiliated to a social security scheme or entitled
  • Patient with contraception (for woman of childbearing age) Specific criteria for idiopathic bronchiectasis patients Patient with idiopathic bronchiectasis in at least two lobes, diagnosis made after extensive screening of known acquired or congenital causes
  • Specific criteria for "control" patients without abnormal ion transport
  • Patient Not having bronchiectasis s or any supposed alteration in transepithelial ion transport
  • Patients with fiberoptic bronchoscopy performed for one of the following indications:
  • Pulmonary malformations
  • Laryngeal, tracheal, bronchomalacia
  • Airway compression
  • Interstitial pathology
  • Suspicion of foreign body
  • Suspected tuberculosis Specific criteria for patients with a typical form of cystic f ibrosis (CF) Patient carrying 2 causing mutations in the CFTR gene (according to CFTR2 database; http://www.cftr2.org/mutations_history.php) and sweat test> 60 milliequivalent per liter (mEq/L).

排除标准

  • Common criteria for all patients
  • Smoking passive or active
  • Not essential bronchial endoscopy in the clinical follow
  • Extension of bronchoscopy time attributed to the difference in potential bronchial incompatible with the patient's general status
  • Patient pregnant or breast feeding
  • Hypersensitivity or cons known contraindications to health products for measurement of DDP (isoproterenol, Amiloride, ATP)
  • Specific criteria for idiopathic DDB patients
  • Presence of other congenital or acquired etiologies of DDB:
  • Typical or atypical cystic fibrosis,
  • Immunodeficiency,
  • Primary ciliary dyskinesia,
  • Abnormal bronchial wall structure (Williams-Campbell syndrome, Mounier-Kuhn, Ehlers-Danlos syndrome, Marfan's disease)
  • Infectious DDBs post
  • Extrinsic or endobronchial obstruction (foreign body, malformation, middle lobe syndrome)
  • Chronic inhalation (GERD, swallowing disorders, gastroesophageal tracheal fistula)
  • Allergic bronchopulmonary aspergillosis,
  • System disease.

结局指标

主要结局

Response to isoproterenol in solution without chloride ions during bronchial potential difference test (ΔIsoprotérénol / bronchial).

时间窗: up to 5 days

Difference between groups for Level of repolarisation

次要结局

  • trans-epithelial ionic transport of sweat epithelium (sweat test)(up to 5 days)
  • trans-epithelial ionic transport in the nasal epithelium (nasal DDP)(up to 5 days)
  • Response to amiloride during bronchial potential difference test(up to 5 days)
  • Basal current short circuit(up to 5 days)
  • Activation of Calcium (Ca)-dependent Chloride (Cl-) ion channels(up to 5 days)
  • Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) (inh-172)(up to 5 days)
  • Response to inhibitors of potassium (K+ ) secretion basolateral(up to 5 days)
  • Inhibition of Solute Carrier family 26, member 9 (SLC26A9)(up to 5 days)
  • Bicarbonate (HCO3- ) secretion in response to forskolin(up to 5 days)
  • Response to Epithelial Sodium Channel (ENaC) inhibitors(up to 5 days)
  • Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)(up to 5 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验